Skip to content

Eye screening for people with diabetes, high blood pressure, and age-related eye problems in rural Odisha using a smartphone camera.

Implementation of smart phone-based fundus camera screening for Diabetic Retinopathy, Hypertensive Retinopathy and Age-related Macular Degeneration in rural primary care: a mixed methods study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/11/096769
Enrollment
60
Registered
2025-11-03
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H353- Degeneration of macula and posterior pole Health Condition 2: I10- Essential (primary) hypertension Health Condition 3: E106- Type 1 diabetes mellitus with other specified complications Health Condition 4: E116- Type 2 diabetes mellitus with other specified complications

Interventions

Intervention1: Training of Community Health Officers for retinal imaging using handheld smartphone-based fundus camera (Remidio Fundus on Phone, Remidio Innovative Solutions Pvt. Ltd., Bengaluru, Indi

Sponsors

Dr Adyasha Das
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Adults aged eighteen years and above with a known diagnosis of hypertension or currently taking antihypertensive medication. 2 Adults aged eighteen years and above with a documented diagnosis of hypertension, defined as: Stage 1 Hypertension: Systolic blood pressure between one hundred thirty and one hundred thirty-nine millimetres of mercury or diastolic blood pressure between eighty and eighty-nine millimetres of mercury. Stage 2 Hypertension: Systolic blood pressure of one hundred forty millimetres of mercury or higher, or diastolic blood pressure of ninety millimetres of mercury or higher. 3 Adults aged eighteen years and above with a known diagnosis of type 1 diabetes mellitus for at least five years. 4 Adults aged eighteen years and above with a known or newly diagnosed case of type 2 diabetes mellitus. 5 Newly diagnosed individuals meeting at least one of the following criteria: Fasting Plasma Glucose of one hundred twenty-five milligrams per decilitre or higher. Two-hour plasma glucose after seventy-five grams oral glucose load of two hundred milligrams per decilitre or higher. Random Blood Sugar of two hundred milligrams per decilitre or higher. Glycated haemoglobin (HbA1c) of six point five percent or higher. 6 Individuals with both diabetes and hypertension will not be included. 7 Adults aged fifty years and above, irrespective of known chronic disease status, for screening of age-related macular degeneration.

Exclusion criteria

Exclusion criteria: 1 Eyes with media opacities, such as dense cataract, that make it impossible to visualize the retina. 2 Participants already diagnosed and currently undergoing active treatment for retinal conditions, such as those who have previously received laser therapy, intravitreal injections, or retinal surgery.

Design outcomes

Primary

MeasureTime frame
Evidence on Implementation outcomes: acceptability, feasibility, sustainability, fidelity of CHO led smartphone-based DR screening of Hypertensive Retinopathy (HR), and Age-Related Macular Degeneration (ARMD). Benefits of the Implementation System-level recommendations for scale-up Timepoint: 3 months

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Adyasha Das

ICMR-RMRCBB

jsk.icmr@outlook.com9937572685

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026